Canada markets closed
  • S&P/TSX

    +187.91 (+0.94%)
  • S&P 500

    +72.88 (+1.73%)
  • DOW

    +424.35 (+1.27%)

    -0.0006 (-0.07%)

    -0.21 (-0.23%)

    -377.05 (-1.20%)
  • CMC Crypto 200

    +3.36 (+0.59%)

    +3.40 (+0.19%)
  • RUSSELL 2000

    +41.36 (+2.09%)
  • 10-Yr Bond

    -0.0390 (-1.35%)

    +267.29 (+2.09%)

    -0.67 (-3.32%)
  • FTSE

    +34.98 (+0.47%)
  • NIKKEI 225

    +727.68 (+2.62%)

    +0.0040 (+0.53%)

Global Positive Airway Pressure Devices Market (2021 to 2030) - Featuring 3B Medical, Apex Medical and Elmaslar Among Others

·10 min read

Dublin, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The "Positive Airway Pressure Devices Market - A Global and Regional Analysis: Focus on Product Type, Indication, End User, Epidemiology, Compliance Rate, Discontinuation, and Regional Analysis - Analysis and Forecast, 2021-2030" report has been added to's offering.

The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030. The market is expected to grow at a CAGR of 6.03% during the forecast period from 2021 to 2030.

A positive airway pressure delivery system is a prescription non-invasive ventilatory device that delivers expiratory positive airway pressure for patients suffering from obstructive sleep apnea. The system also provides positive airway pressure during incipient apnea. The system may include a dedicated flow generator and a patient interface.

Sleep apnea is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing the soft tissue at the back of the throat to collapse and block the upper airway. Obstructive sleep apnea is also one of the independent risk factors for stroke, cardiovascular diseases, and systemic hypertension, among other clinical consequences. Globally, sleep apnea impacts more than 936 million individuals worldwide. The American Academy of Sleep Medicine (AASM) recommends that continuous positive airway pressure (CPAP) devices be considered first-line treatment for moderate and severe OSA.

Despite the recommendations, CPAP devices and PAP devices in general frequently encounter challenges in terms of adherence. There are a number of factors that contribute to the low adherence rates for PAP devices. These factors primarily include claustrophobia, discomfort, and high cost. Several studies have been conducted to identify the reason behind low adherence rates despite several changes in the device and mask dynamics.

Key Companies Profiled

3B Medical, Inc, Apex Medical Corporation, BMC Medical Co. Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited, Hebei Topson Medical Technology Co., Ltd., Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Lowenstein Medical Technology GmbH + Co. KG., Narang Medical Limited, ResMed Inc., Somnetics International, Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of positive airway pressure devices, they will be able to do the following:

  • Understand their position as compared to some of the key players in the market

  • Get information on parameters such as device adoption rate, therapy compliance rate, and discontinuation rate

  • Assess the disease epidemiology in each region

  • Familiarize themselves with the necessary information related to changing market dynamics

  • Stay updated with the latest trends in the market with respect to connected devices

  • Understand the impact of COVID-19 on the market

  • Identify some of the key players in the market and understand their value contribution

Key Questions Answered in the Global Positive Airway Pressure Devices Market Report:

  • How has COVID-19 impacted the adoption of PAP devices in the market?

  • What are the key regulations which influence the adoption of PAP devices in the market?

  • What are some of the key companies in the global and regional PAP market?

  • What are some of the key factors influencing the growth in adopting PAP devices across the globe?

  • What are some of the growth opportunities which market players can capitalize on?

  • What is the PAP device adoption rate for patients diagnosed with sleep apnea?

  • What are the compliance and discontinuation rates for PAP therapy across regions?

  • What are the fastest-growing countries in terms of PAP devices adoption?

  • Which are the key diseases driving the adoption of PAP devices across the world?

  • What are the key strategies being adopted by market players in the global positive airway pressure devices market?

  • Who are the most common end-users of PAP devices, and how are the end-use segment expected to grow in the future?

Global Positive Airway Pressure Devices Market Drivers

Currently, the market is mainly being driven by the growing prevalence of obstructive sleep apnea and chronic respiratory diseases. Some countries have registered increasing awareness of the benefits of positive airway pressure (PAP) therapy, and as a result, there has been a hike in the prevalence of PAP therapy in those countries in the past few years.

There has been a steady growth in the number of health-tech startups in the industry. The market entry of new players has been further accelerated by the COVID-19 pandemic. MedTech startups have been responding to the growing demand for ventilators by offering non-invasive unconventional systems and indigenous ventilators. Apart from that, globally, the prevalence of obstructive sleep apnea is expected to exceed 986 million cases by the end of 2026. According to data obtained from the Global Data Health Exchange and BIS Research analysis, the incidence of the condition in North America was as high as 1 in 11 individuals in 2020. The life expectancy in most countries has surged tremendously. The improvement in life expectancy is due to significant advancements in diagnostic technology and medical science. Furthermore, growing awareness regarding health, nutrition, and hygiene has also resulted in increased life expectancy.

The prevalence of diseases among the growing geriatric population has grown at a significant pace during 2015-2019 as compared to those aged 54 and below.

Global Positive Airway Pressure Devices Market Challenges

The primary challenge is the lack of awareness of the benefits of positive airway pressure therapy among individuals. Sleep apnea itself faces a significant challenge in getting diagnosed with many individuals unaware that they suffer from the condition. A key restraining factor to the growth in the adoption of PAP devices is their high cost. Additionally, the lack of reimbursement policies by the government and commercial payors also hampers the adoption of PAP devices in emerging economies. These devices are also uncomfortable for many users, which results in the discontinuation of therapy. The global positive airway pressure devices market is also expected to be restrained due to non-adherence.

Global Positive Airway Pressure Devices Market Opportunities

Owing to the rising focus on remote patient monitoring, mobile health applications, and integration of telemedicine in treatment and diagnostic aspects of healthcare, the development of smart PAP devices offers a novel opportunity to both established and emerging players.

Established PAP device manufacturers can develop devices integrated with a mobile application that would enable patients to monitor their breathing quality, sleep quality, and therapy adherence. Moreover, the mobile application could further facilitate data sharing with a physician for patient monitoring. For instance, Koninklijke Philips N.V. developed DreamMapper, a mobile application compatible with its CPAP devices. The mobile application offers various features such as therapy hours, educational information, progress monitoring, and data sharing with physicians.

Impact of COVID-19 on the Positive Airway Pressure Devices Industry

The impact of COVID-19 varies depending on the region, country, the extent of lockdowns, and the perception of the local population.

The market witnessed a temporary boost in demand when CPAP devices were approved for emergency use by regulatory bodies to bridge the gap between demand for and supply of ventilators.

Key areas of the supply chain were impacted during the initial days of the pandemic, which comprised coinciding lockdowns in several countries leading to a restriction in global logistics. The resulting strain led to reduced stock in warehouses and a hike in logistics costs locally.

Key Topics Covered:

1 Product Definition

2 Scope of Research
2.1 Scope of Study
2.2 Inclusion and Exclusion Criteria
2.3 Key Questions Answered in the Report

3 Research Methodology
3.1 Data Collection and Analysis
3.2 Data Sources
3.2.1 Primary Data Sources
3.2.2 Secondary Data Sources
3.3 Data Triangulation
3.4 Market Estimation
3.5 Forecast Period Selection Criteria
3.6 Assumptions and Limitations

4 Epidemiological and Reimbursement Landscape for PAP Devices
4.1 Epidemiological Landscape
4.1.1 Obstructive Sleep Apnea (OSA) Regional Analysis for PAP Devices
4.1.2 Chronic Obstructive Pulmonary Disorder (COPD) Regional Analysis for PAP Devices
4.1.3 COVID-19 Regional Analysis for PAP Devices
4.1.4 Other Respiratory Disorders
4.2 Reimbursement Landscape
4.2.1 North America
4.2.2 Europe
4.2.3 Asia-Pacific

5 Impact of COVID-19 on Global Positive Airway Pressure (PAP) Devices Market
5.1 Impact on Regulatory Authorities
5.2 Impact on Adoption of Positive Airway Pressure Devices
5.3 Impact on Market Size of Positive Airway Pressure Devices
5.3.1 Scenario Comparison Analysis
5.3.2 Regional Impact
5.4 Future Impact of COVID-19
5.4.1 Short-Term Impact (2-4 Years)
5.4.2 Mid-Term Impact (5-10 Years)
5.4.3 Long-Term Impact (8-12 Years)
5.5 Entry Barriers and Opportunities for New Companies

6 Industry Analysis
6.1 Industry Structure
6.2 Key Technological Trends
6.2.1 Short-Term Potential (2-4 Years)
6.2.2 Mid-Term Potential (4-8 Years)
6.2.3 Long Term Potential (8-12 Years)
6.3 Value Chain/Supply Chain Analysis
6.4 Regulatory Framework
6.4.1 Regulations in North America Food and Drug Administration (FDA) Health Canada
6.4.2 Regulations in Europe
6.4.3 Regulations in Asia-Pacific National Medical Products Administration (NMPA) Pharmaceutical and Medical Device Agency (PMDA)
6.5 Patent Analysis
6.5.1 Awaited Technological Developments
6.5.2 Patent Trend (by Year)
6.5.3 Patent Trend (by Country/Cluster)

7 Competitive Landscape
7.1 Market Share Analysis
7.2 Key Developments and Strategies
7.2.1 New Offerings
7.2.2 Partnerships, Alliances, and Business Expansions
7.2.3 Regulatory and Legal Activities
7.2.4 Mergers and Acquisitions
7.3 Business Model Analysis
7.4 Pricing Analysis

8 Global Positive Airway Pressure (PAP) Devices Market
8.1 Assumptions and Limitations
8.2 Key Findings and Opportunity Assessment
8.3 Global Positive Airway Pressure Devices Market Growth Scenario
8.3.1 Realistic Growth
8.3.2 Optimistic Growth
8.3.3 Pessimistic/Conservative Growth
8.4 Market Dynamics
8.4.1 Impact Analysis
8.4.2 Growth Promoting Factors Rising Number of Startups Driving Innovation Increasing Prevalence of Obstructive Sleep Apnea Growing Prevalence of Respiratory Diseases among the Geriatric Population Growing Prevalence of Chronic Respiratory Diseases across the Globe
8.4.3 Growth Inhibiting Factors High Upfront Cost of the Devices Side-Effects Associated with Long-Term Usage
8.4.4 Growth Opportunities Development of Smart PAP Devices Deployment of 3D Scanning to Offer Customized PAP Masks Development of Accessory-Free PAP Devices Regional Analysis of Growth Opportunities

9 Global Positive Airway Pressure Devices Market (by Product Type)
9.1 Opportunity Assessment
9.2 Growth-Share Matrix
9.3 Continuous Positive Airway Pressure Device (CPAP)
9.4 Automatic Positive Airway Pressure Device (APAP)
9.5 Bi-Level Positive Airway Pressure Device (BiPAP)

10 Global Positive Airway Pressure Devices Market (by Indication)
10.1 Opportunity Assessment
10.2 Growth-Share Matrix
10.3 Sleep Apnea
10.4 Chronic Obstructive Pulmonary Disease (COPD)
10.5 Others

11 Global Positive Airway Pressure Devices Market (by End User)
11.1 Opportunity Assessment
11.2 Growth-Share Matrix
11.3 Sleep Laboratories
11.4 Home Care
11.5 Others (Hospitals and Clinics, Elderly Care Homes, Nursing Homes, etc.)

12 Global Positive Airway Pressure Devices Market (by Region)

13 Company Profiles

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting